<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.1)*
Clinicor, Inc.
------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
------------------------------
(Title of Class of Securities)
18726M106
------------------------------
(CUSIP Number)
December 31, 1999
------------------------------
(Date of Event Which Requires Filing of this Statement)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
Rule 13d-1(b)
----
Rule 13d-1(c)
----
X Rule 13d-1(d)
----
Page 1 of 5 pages
<PAGE>
CUSIP No. 18726M106
- -------------------------------------------------------------------------------
1. Name of Reporting Person and S.S. or I.R.S. Identification Number
Robert S. Sammis
- -------------------------------------------------------------------------------
2. Check the Appropriate Row if a Member of a Group
a. N/A
b. N/A
- -------------------------------------------------------------------------------
3. SEC Use Only
- -------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U. S. citizen
- -------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each Reporting Person With:
5. Sole Voting Power 1,141,283 shares (see Item 4)
6. Shared Voting Power N/A
7. Sole Dispositive Power 1,141,283 shares (see Item 4)
8. Shared Dispositive Power N/A
- -------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,141,283 shares (see Item 4)
- -------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
N/A
- -------------------------------------------------------------------------------
Page 2 of 5 pages
<PAGE>
11. Percent of Class Represented by Amount in Row (9)
26.4%
- -------------------------------------------------------------------------------
12. Type of Reporting Person
IN
- -------------------------------------------------------------------------------
Page 3 of 5 pages
<PAGE>
Item 1(a). Name of Issuer:
Clinicor, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
1717 West Sixth Street, Suite 400
Austin, Texas 78703
Item 2(a). Name of Person Filing:
Robert S. Sammis
Item 2(b). Address of Principal Business Office:
1717 West Sixth Street, Suite 400
Austin, Texas 78703
Item 2(c). Citizenship/State of Organization:
U.S. citizen
Item 2(d). Title of Class of Securities:
Common Stock, par value $.001 per share
Item 2(e). CUSIP Number:
18726M106
Item 3. Filing pursuant to Rule 13d-1(b):
N/A
Item 4. Ownership:
(a) Amount Beneficially Owned: 1,141,283 shares
(b) Percent of Class: 26.4%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote: 1,141,283
shares
(ii) shared power to vote or to direct the vote: N/A
(iii) sole power to dispose or to direct the disposition of:
1,141,283 shares
Page 4 of 5 pages
<PAGE>
(iv) shared power to dispose or to direct the disposition
of: N/A
Note: The 1,141,283 shares of Common Stock beneficially owned by
Mr. Sammis include (1) 291,283 shares owned by other shareholders
as to which Mr. Sammis and Mr. Thomas O'Donnell have entered into
agreements pursuant to which Mr. Sammis and Mr. O'Donnell are
jointly entitled to direct the manner in which such shares shall
be voted and (2) 150,000 shares issuable to Mr. Sammis pursuant to
options exercisable within sixty days of December 31, 1999.
Item 5. Ownership of Five Percent or Less of a Class:
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company:
N/A
Item 8. Identification and Classification of Members of the Group:
N/A
Item 9. Notice of Dissolution of Group:
N/A
Item 10. Certification:
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Section 13G is true, complete and
correct.
Dated: February 10, 2000 /s/ Robert S. Sammis
--------------------------
Robert S. Sammis
Page 5 of 5 pages
